Health Minister Hsueh Jui-yuan (薛瑞元) said Wednesday the ministry's commissioning of Choice Pharma Taiwan to conduct Phase 2 clinical trials of the locally manufactured Medigen COVID-19 vaccine predated a merger between Choice Pharma's parent company and a Shanghai-based firm, amid controversy over possible Chinese involvement in the trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Typhoon Danas makes landfall in Taiwan's Chiayi County
07/07/2025 01:07 AM - Society
Northern Taiwan cities declare business as usual Monday despite storm
07/06/2025 09:26 PM - Society
Typhoon Danas outer band touches southern Taiwan, rain intensifies
07/06/2025 09:26 PM - Society
High speed rail to only run all-stop, non-reserved trains Monday
07/06/2025 09:17 PM - Society
6 cities/counties to close schools, offices Monday due to typhoon
07/06/2025 06:13 PM